A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients
NCT02092233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1963
Last updated 2015-07-10
Summary
The ARIES HSV 1\&2 Assay is a PCR based test for the direct detection and typing of herpes simplex virus (HSV 1 \& 2) DNA.
The objective is to establish the diagnostic accuracy of ARIES HSV-1\&2 Assay.
Conditions
- Herpes
Sponsors & Collaborators
-
Luminex Corporation
lead INDUSTRY
Principal Investigators
-
David Himsworth · Luminex Corporation
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
NCT00076232 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
NCT00371592 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood
NCT00001115 ·Status: COMPLETED ·Phase: NA
-
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
NCT04950712 ·Status: COMPLETED
-
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
NCT05432583 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
NCT04294030 ·Status: WITHDRAWN
-
A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes
NCT06698575 ·Status: COMPLETED ·Phase: PHASE1
-
HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population
NCT00655434 ·Status: COMPLETED
-
Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2
NCT04222985 ·Status: TERMINATED ·Phase: PHASE1
-
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
NCT00486200 ·Status: COMPLETED ·Phase: PHASE2
-
Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
NCT04165122 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand
NCT00362596 ·Status: COMPLETED ·Phase: PHASE4
-
Open-label Study of ASP2151 in Herpes Simplex Patients
NCT02209324 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
NCT02030301 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
NCT00362297 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating New Formulation of Therapeutic HSV-2 Vaccine
NCT02515175 ·Status: COMPLETED ·Phase: PHASE2
-
New Multiplex Real-time PCR for Genital Ulcer Disease
NCT01688258 ·Status: COMPLETED
-
HSV-2 Shedding Resolution After Acyclovir Treatment
NCT00495573 ·Status: COMPLETED
-
Structure of the Herpes Simplex Virus Receptor
NCT00001648 ·Status: COMPLETED
-
Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
NCT01658826 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
NCT06033261 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
NCT02114060 ·Status: COMPLETED ·Phase: PHASE2
-
Viral Infections in Healthy and Immunocompromised Hosts
NCT01306084 ·Status: RECRUITING
-
Herpevac Neonatal Substudy
NCT00138320 ·Status: TERMINATED
-
Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
NCT01047540 ·Status: COMPLETED ·Phase: PHASE2